EBIT at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's EBIT?
- ANI Pharmaceuticals (ANIP) reported EBIT of $38.89M in Q1 2026.
- How has ANI Pharmaceuticals's EBIT changed year-over-year?
- ANI Pharmaceuticals's EBIT increased by 48.5% year-over-year, from $26.19M to $38.89M.
- What is the long-term trend for ANI Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's EBIT has grown at a 29.3% compound annual growth rate (CAGR), from -$39.79M to $111.09M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.